OMERS Administration Corp’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,000
Closed -$327K 329
2018
Q3
$327K Buy
+10,000
New +$327K ﹤0.01% 332
2017
Q3
Sell
-9,500
Closed -$378K 508
2017
Q2
$378K Hold
9,500
﹤0.01% 403
2017
Q1
$350K Buy
9,500
+2,300
+32% +$84.7K ﹤0.01% 289
2016
Q4
$230K Sell
7,200
-13,900
-66% -$444K ﹤0.01% 292
2016
Q3
$765K Hold
21,100
0.01% 397
2016
Q2
$479K Buy
21,100
+7,272
+53% +$165K 0.01% 462
2016
Q1
$260K Buy
13,828
+2,419
+21% +$45.5K 0.01% 497
2015
Q4
$187K Buy
+11,409
New +$187K ﹤0.01% 463